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Lymph nodes are constructed of intricate
networks of stromal cells. Gregory et al.
reveal a robust yet transient
transcriptional program in lymph node
stromal cells induced by virus infection.
Previously primed lymph nodes
sustained amplified networks of stromal
cells that supported subsequent immune
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Lymph nodes (LNs) are constructed of intricate net-
works of endothelial andmesenchymal stromal cells.
How these lymphoid stromal cells (LSCs) regulate
lymphoid tissue remodeling and contribute to im-
mune responses remains poorly understood. We
performed a comprehensive functional and tran-
scriptional analysis of LSC responses to skin viral
infection and found that LSC subsets responded
robustly, with different kinetics for distinct patho-
gens. Recruitment of cells to inflamed LNs induced
LSC expansion, while B cells sustained stromal re-
sponses in an antigen-independent manner. Infec-
tion induced rapid transcriptional responses in
LSCs. This transcriptional programwas transient, re-
turning to homeostasis within 1 month of infection,
yet expanded fibroblastic reticular cell networks per-
sisted formore than 3months after infection, and this
altered LN composition reduced the magnitude of
LSC responses to subsequent heterologous infec-
tion. Our results reveal the complexity of LSC re-
sponses during infection and suggest that amplified
networks of LN stromal cells support successive im-
mune responses.INTRODUCTION
The secondary lymphoid organs function as a surveillance net-
work to capture pathogens and initiate immune responses. The
organized microarchitecture of lymph nodes (LNs) facilitates in-
teractions by immune cells within a complex network of endothe-
lial and mesenchymal stromal cells (Brown and Turley, 2015;
Fletcher et al., 2015; Mueller and Germain, 2009). LNs are encap-406 Cell Reports 18, 406–418, January 10, 2017 ª 2017 The Author(s
This is an open access article under the CC BY-NC-ND license (http://sulated structures throughwhich lymph is filtered, entering the LN
subcapsular sinus that connects to the cortical and medullary
lymphatics. Lymphocytes migrating through an LN enter the
lymphatic sinuses, where they can proceed to the next LN in
the lymphatic chain and ultimately re-enter the bloodstream via
the thoracic duct. T cells that enter LNs via afferent lymphatics,
either from tissues or upstream LNs, can enter via medullary si-
nuses, whereas dendritic cells (DCs) that migrate from the tissues
are able to cross the lymphatic floor of the subcapsular sinus
(SCS) (Schulz et al., 2016). Cells that enter LNs from the blood
do so via specialized blood vessels composed of phenotypically
distinct blood endothelial cells (BECs). These high endothelial
venule (HEV) cells express molecules required for cells to enter
LNs, including peripheral node addressin (PNAd). HEVs are
concentrated in certain areas of LNs, particularly in the outer par-
acortex (cortical ridge) between the T and B cell zones.
Networks of mesenchymal stromal cells construct and define
the boundaries of the different compartment of LNs. Fibroblastic
reticular cells (FRCs) are found in T cell zones, where they pro-
duce and ensheath collagen-rich reticular fibers and construct
a conduit network through which small molecules can filter into
LNs (Gretz et al., 2000; Sixt et al., 2005). T cell zone FRCs are
defined by expression of markers, including gp38 (podoplanin),
and production of homeostatic cytokines (interleukin 7 [IL-7])
and chemokines (CCL21 and CCL19) that are required for
lymphocyte migration and homeostasis (Mueller and Germain,
2009). FRCs are also found within the LN medulla. Another sub-
set of gp38+ mesenchymal stromal cells forms a network under-
neath the SCS adjacent to B cell follicles. These marginal retic-
ular cells (MRCs) express many markers of other stromal cells,
as well as mucosal vascular addressin cell adhesion molecule
1 (MADCAM-1) and high levels of the receptor activator of nu-
clear factor kB (NF-kB) ligand (RANKL). Within B cell zones,
follicular dendritic cells (FDCs) form a dense network in the
follicle center, whereas other B cell zone reticular cells (BRCs)
construct the follicle boundaries. Both FDCs and BRCs express
the chemokine CXCL13, while FDCs express Fc receptors (such).
creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Lymphoid Stromal Cell Responses to Infection
(A) Immunofluorescence staining of medial bLN sections for CD3 and B220 at different times after skin HSV infection.
(B) Quantitation of bLN and non-draining inguinal lymph node (iLN) sections for total area and T and B cell zone regions. n = 4–6 mice per time point.
(C) gp38 staining in the T cell zone of bLNs of uninfected mice and 7 days after HSV infection.
(legend continued on next page)
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as CD16 and CD32), complement receptors (CD21 and CD35),
and complement components.
The lymphoid stromal cell (LSC) subsets have been shown to
influence immunity and contribute to T cell responses in several
ways. In addition to lymphocyte migration and homeostasis (Ba-
je´noff et al., 2008; Link et al., 2007; Luther et al., 2000), FRCs can
induce peripheral T cell tolerance (Baptista et al., 2014; Dubrot
et al., 2014; Fletcher et al., 2010) and restrict T cell proliferation
(Khan et al., 2011; Lukacs-Kornek et al., 2011; Siegert et al.,
2011). Moreover, deletion of CCL19-expressing LSCs demon-
strated a critical role for intact LSC networks for lymphocyte
and dendritic cell homeostasis (Cremasco et al., 2014). Recent
elegant studies also demonstrated functional roles for gp38 ex-
pressed on LSCs for DC migration through engagement of the
C-type lectin domain family 1 member B (CLEC2) and for inhibit-
ing FRC contractility via CLEC2 binding (Acton et al., 2012, 2014;
Astarita et al., 2015). This latter observation suggests that FRC
networks in LNs might stretch to accommodate increases in
cellularity induced rapidly by inflammation. Following immuniza-
tion of mice with ovalbumin in complete Freund’s adjuvant (OVA/
CFA), the major subsets of LSCs were shown to proliferate to
control LN growth (Abe et al., 2014; Chyou et al., 2011; Yang
et al., 2014). Similarly, infections induce substantial hypertrophy
of draining LNs. However, what signals control these LSC re-
sponses, whether these are tailored to the inflammatory milieu
induced by different pathogens, and how LSCs respond to infec-
tion at the molecular level are not known.
In this study, we examined responses by LN FRC, lymphatic
endothelial cell (LEC), and BEC populations to skin virus infec-
tion. The LSCs responded rapidly and robustly to infection,
proliferating and significantly modulating gene expression. We
show that expansion of FRC networks was long-lived, but the
transcriptional program induced by infection was transient. Pri-
mary infection with different viral pathogens induced distinct
patterns of LSC expansion, yet all induced sustained remodeling
that altered responses induced by a subsequent infection. Thus,
we provide insight into the cellular and molecular mechanisms
driving the remodeling of LN LSCs during primary and secondary
immune challenges.
RESULTS
LN Remodeling and Expansion of LSCs after Cutaneous
HSV Infection
To begin to examine how LNs are remodeled during infection to
support the generation of the immune response, we utilized a
well-established model of localized skin infection with herpes
simplex virus type 1 (HSV-1). Mice infected on the flank prime
adaptive immune responses in the primary draining brachial(D) Immunofluorescence staining of bLNs for CD31, PNAd, and LYVE-1 to identif
LYVE-1+) at different times after skin HSV infection.
(E) Analysis of cell populations in bLN and non-draining iLN by flow cytometry af
(F) Proliferation of LSC subsets after HSV infection. Micewere treatedwith BrdU in
time point.
(G) Upregulation of Ki67 in gp38+ FRCs after infection. bLN sections were staine
Error bars represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0
Kruskal-Wallis test followed by Dunn’s multiple-comparisons test (E and F). *p =
408 Cell Reports 18, 406–418, January 10, 2017LN (bLN). HSV-1 is an acute infection that is cleared from the
skin of mice within 1 week and remains latent in dorsal root
ganglia. We have shown that priming of T cell responses after
skin HSV-1 infection is rapid and involves an increase in the
size of the draining bLN within days (Hor et al., 2015). Visualiza-
tion of medial bLN sections by microscopy confirmed a marked
increase in bLN size (Figures 1A and 1B), which reached a
maximum at 1 week after infection. This 4-fold increase in
bLN cross-sectional area contracted after day 7 yet remained
increased for more than 30 days compared to non-draining
LN. Measurement of T and B cell regions by co-staining for
CD3 and B220 revealed similar kinetics of expansion in volume
of these compartments, with B cell zones remaining enlarged
30 days after infection (Figure 1B).
The gp38+ stromal network in bLNs was increased in size cor-
responding to the enlarged T cell zones. On day 7, the gp38+
network in the T cell zones was less organized and denser, but
it did not appear disrupted or overtly damaged (Figure 1C).
gp38+ cells within the medulla also expanded appreciably after
infection (Figure S1A). These nodular regions were surrounded
by LYVE-1+ lymphatics and contained T and B cells as well as
blood vessels that were mostly PNAd+ HEVs. We also examined
changes in the blood and lymphatic vasculature. LYVE-1+
lymphatic structures were increased and there was marked
expansion of LN blood vessels, in particular PNAd+ HEVs, on
day 15 after infection (Figure 1D).
To enumerate populations of stromal cells in bLNs we enzy-
matically digested individual LNs after HSV-1 infection. Single-
cell suspensions were stained for gp38 and CD31 to identify
the major LN stromal cell subsets among CD45 cells: FRCs,
LECs, and BECs (Figure S1B). We also co-stained BECs for
PNAd to identify HEV endothelial cells. Mock infection (skin scar-
ification plus PBS) did not induce LN hypertrophy or an increase
in numbers of LSCs in bLNs (Figure S1C). After HSV infection, to-
tal cellularity in bLNs increased significantly within 3 days, peak-
ing by day 7 and gradually contracting, yet it remained increased
for at least 1 month (Figure 1E). T and B cell and DC numbers in
bLNs peaked by day 7 after infection, contracted slowly, and re-
mained marginally increased at day 30 but returned to pre-infec-
tion levels by day 90 (Figure S1D). Expansion of bLN FRCs was
slightly delayed compared with total cellularity, beginning at day
5 and peaking by day 15 at levels >20-fold higher than in unin-
fected LNs (Figure 1E). Although the bLN FRC compartment
contracted after day 15, numbers of FRCs remained significantly
increased for at least 3 months after infection. This suggested
that remodeling of the LN FRC compartment was sustained after
peripheral viral infection. Similarly, LECs expanded >10-fold
after infection, peaking at day 15, and remained elevated for at
least 1 month. BECs expanded later than FRCs and LECs, withy blood vessels (CD31+), HEVs (CD31+ PNAd+), and lymphatic vessels (CD31+
ter HSV infection. n = 6–24 mice per time point.
drinking water for the indicated periods of days after infection. n = 5–8mice per
d for gp38 and Ki67. n = 4–5 mice.
.0001 by one-way ANOVA with Holm-Sidak’s multiple-comparisons test (B) or
0.0159 by two-tailed Mann-Whitney test (G). See also Figure S1.
Figure 2. Gene Expression Changes in LSC Subsets Induced by Infection
(A) Volcano plots of FRCs, LECs and BECs from bLN 3, 6, and 30 days after HSV infection showing differentially expressed genes compared to uninfected mice.
Differentially expressed genes are shown in red. Numbers refer to number of genes either downregulated (top left) or upregulated (top right) in each comparison.
(B) Comparison of differential gene expression within each LSC subset at different time points after HSV infection. Numbers represent genes up/downregulated in
each comparison.
(C) GO term enrichment in FRCs, LECs or BECs at day 6 compared to cells from uninfected mice.
See also Figure S2.a lower magnitude (4-fold), yet also peaked in number at day 15.
The PNAd+ subset of BECs expanded substantially after day 7
(8-fold), reflecting the large number of PNAd+ vessels observed
in bLN sections at day 15 (Figure 1D). In contrast, the
CD45CD31gp38 (double negative [DN]) population, which
consists of pericytes and other unidentified LN stromal cells
(Malhotra et al., 2012), peaked at day 7 before contracting to
baseline within 30 days (Figure S1D).
Each of the three main LSC subsets proliferated robustly after
HSV infection, with 40%–50% of FRCs, LECs, and BECs incor-
porating bromodeoxyuridine (BrdU) within the first week (Fig-
ure 1F). Confocal microscopy on sections from bLN 6 days after
infection revealed substantial numbers of gp38+ Ki67+ cells, indi-
cating proliferation (Figure 1G). These Ki67+ gp38+ cells were
distributed throughout the bLNs as opposed to foci of expanding
cells. After day 7, FRCs and LECs showed reduced BrdU uptake,
indicating that much of the proliferation of these cells occurred
within the first week of the infection. In contrast, BECs continued
to proliferate until day 11 (Figure 1F). Concomitant with expan-
sion, FRCs showed marked upregulation of gp38, which peaked
1 week after infection and returned to baseline within 30 days
(Figure S1E). Together these data demonstrate that LN stromal
cells respond robustly to peripheral virus infection and maintain
an enlarged LN microenvironment for prolonged periods after
clearance of infection.
Prominent Transcriptional Changes in LSC Subsets
Induced after Infection
To investigate gene expression changes in FRCs, LECs, and
BECs throughout the course of peripheral infection we sorted
these LSC subsets to high purity from bLNs obtained from naive
mice and mice infected with HSV 3, 6, and 30 days previously
(Figure S2A) and then profiled the RNA samples using Affymetrixmicroarrays. Principal-coordinate analysis showed that the three
LSC subsets have distinct expression profiles and confirmed
that the transcriptional identity of these subsets was unchanged
by infection (Figure S2B). We examined expression of previously
identified genes known to be expressed by each cell subset,
confirming the identity of the cells (Figure S2C).
Hierarchical clustering of differentially expressed probes within
each LSC subset demonstrated abundant changes in gene
expression after infection (Figure S2D). To prioritize the most
important genes, we assessed differential expression induced
by infection using the TREAT (t tests relative to a threshold)
method (McCarthy and Smyth, 2009), which requires fold
changes (FCs) to be significantly above aminimum threshold. Us-
ing a false discovery rate (FDR) of 5%, we compared gene
expression within each subset at various time points after infec-
tion to that of uninfected cells of the same cell type. The TREAT
method evaluates variability as well as well as the magnitude of
change in expression values and therefore is not equivalent to a
simple fold change cutoff. Nevertheless, almost all the statistically
significant expression changes were greater than 1.5-fold and
most were greater than 2-fold. Within 3 days of infection, bLN
FRCs up- or downregulated over 470 genes and LECs over 100
genes (Figure 2A). Notably, at this early time point, BECs showed
almost no differential gene expression. By day 6 (roughly the peak
of the T cell response to HSV), FRCs showed regulation of >1,500
genes (1,030 upregulated and 543 downregulated), while LECs
and BECs had >2,000 and >450 differentially expressed (DE)
genes, respectively. Remarkably, this response was entirely tran-
sient, with gene expression by each subset returning to baseline
within 30 days of infection (Figure 2A).
Evaluation of genes regulated during HSV infection within
each stromal cell subset revealed that most transcriptional
changes that began early (by day 3) continued until day 6, withCell Reports 18, 406–418, January 10, 2017 409
Figure 3. Identification of Genes Regulated
in LSC Subsets after Infection
(A) Comparison of differentially expressed genes in
FRCs, LECs, and BECs 6 days after HSV infection.
Numbers represent genes up- or downregulated in
each comparison.
(B–D) Heatmaps depicting log2 expression fold-
changes (log2 FCs) of differentially expressed
genes in FRCs, LECs, and BECs at different time
points after HSV infection. (B) Cohorts of genes
regulated similarly in all three LSC subsets at day 6.
(C) Cohorts of genes regulated similarly in two of
the three LSC subsets. (D) Genes uniquely regu-
lated in FRCs 6 days after infection compared to
that in LECs and BEC.
See also Figure S3.relatively few genes uniquely regulated at day 3 (Figure 2B). Most
gene expression regulation occurred between days 3 and 6
(Tables S1 and S2). The DE genes in each LSC subset showed
enrichment for similar functional pathways, including cell divi-
sion, antigen presentation, extracellular matrix, and apoptosis,
as well as prominent defense and immune response pathways
(Figure 2C).
Comparison of DE genes in FRCs, LECs, andBECs 6 days after
infection revealed a cohort of >100 genes regulated significantly410 Cell Reports 18, 406–418, January 10, 2017in the same direction in all three cell types
(Figures 3A and 3B; Table S1). These
included multiple genes involved in cell
division (e.g., Mki67, Ccna2, Ccnb1/2,
Prr11, and Foxm1), the interferon
response (e.g., Gbp2/3/4/5/6/8/9/11,
Irgm1/2, and Stat1/2), the chemokine
Cxcl9, and the transcription factor Batf2.
Multiple major histocompatibility complex
class II (MHC II) genes were upregulated,
and staining of cells 7 days after infection
confirmed increased MHC II expression
by FRCs, LECs and BECs (Figure S4A).
The PYHIN protein family member Ifi205
and the Z-DNA-binding protein 1 (Zbp1),
which function as DNA sensors, were up-
regulated in all three subsets of LSCs. Ver-
sican (Vcan), an extracellular matrix pro-
tein that interacts with various partners,
including chemokines and hyaluronan,
and may regulate cell contractility (Hirose
et al., 2001; Wight, 2002), was also signif-
icantly upregulated in FRCs, LECs, and
BECs. Some genes, including Apoe,
Cxcl1, Icam1, and Trf, as well as the tran-
scription factors Egr3, Fos, and Nr4a1
(Nur77), were uniformly downregulated in
the LSC subsets.
We also found that numerous genes
were regulated significantly in two of the
three LSC subsets (Figure 3C), althoughthis often also involved similar non-significant changes in gene
expression in the third LSC subset. These included the Tim-3
ligand galectin-9 (Lgals9) the defense gene Mpeg1, smooth
muscle actin (Acta2), interferon-induced genes (including
Oas1g, Ifit1, Ifitm1), and the transcription factor Irf7. Many genes
were coregulated by FRCs and LECs (245 genes). These
included Aqp1, Ccl20, Ly6a (also known as Sca-1), and the
anti-bacterial protein lipocalin-2 (Lcn2). In contrast, FRCs and
BECs, as well as LECs and BECs, showed coregulation of only
Figure 4. Induction and Maintenance of LSC Expansion after Infection Requires B Cells
(A) Expression of FABP7 mRNA in fluorescence-activated cell sorting (FACS) sorted FRCs 3 and 6 days after HSV infection, determined by RT-PCR. n = 4.
(B) Normal expansion of LSC subsets in the bLN of FABP7/ mice after HSV infection. n = 5–7 mice per time point.
(C) LSCs do not expand in IFN-aR/ mice after HSV infection. Mice were transferred with in-vitro-activated gBT-I T cells 3 days after infection to prevent viral
spread to the CNS. n = 6 mice per time point.
(D) Blocking T cell recruitment to the bLN inhibits FRC expansion after HSV infection. Mice were treated with anti-aL and anti-a4 antibodies on days 1, 3, and 5
after infection and analyzed at day 7. n = 8 mice per group.
(E) Expansion of the bLN and FRCs is normal in TCR-a/ mice. Mice were infected with HSV or transferred with 106 gBT-I CD8 and gDT-II CD4 T cells prior to
infection and analyzed 7 days post-infection. Control mice were uninfected and a control group also transferred with transgenic T cells for 7 days. n = 6–15 mice
per group.
(F) Expansion of bLNs and FRCs is impaired in RAG1/ mice. Mice were infected with HSV and analyzed 5 days post-infection. n = 13–14 mice per group.
(G) T cells induce LSC expansion in RAG1/mice after HSV infection that contracts after day 7. RAG1/mice were transferredwith 23 107 non-enriched B6 LN
cells, 23 107 enriched naive T cells, or 106 naive gBT-I and gDT-II T cells prior to HSV infection. LSCswere analyzed in bLN 7 and 15 days later. Shown are the fold
changes in LSC numbers at day 15 relative to day 7. n = 6 mice per group.
(H) B cells sustain LSC numbers in mMT/ mice after HSV infection. mMT/ mice in one group were transferred with 2 3 107 enriched naive B cells prior to
infection. Control micewere uninfected and also received transferred cells for 7 or 15 days. Shown are the fold changes in LSC numbers at day 15 relative to day 7.
n = 6–11 mice per group.
(legend continued on next page)
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small cohorts of genes (71 and 50 genes, respectively). LECs and
BECs both upregulated the chemokines Cxcl10 and Cxcl13, the
decorin protein (Dcn) that can regulate cell cycle, and the C1-in-
hibitor Serping1. Thy1 was also upregulated in all LSC subsets,
although significantly only in FRCs. Staining of cells ex vivo
revealed that a proportion of FRCs and LECs upregulated Thy1
after infection (Figure S4A).
Many genes were upregulated uniquely in FRCs after infection
(986 genes). These included Ifngr2, Il2rg, Il15ra, Il15, Il33,
Tmem173 (STING), Ccl8, and Ccl9 (Figure 3D; Table S1). Other
genes highly upregulated in FRCs included fatty-acid-binding
protein Fabp7; the adhesion molecules Chl1, Dsc2, and Ncam;
the acute phase response protein Saa3; the receptor Timd4;
and the adrenergic receptor Adra2a. The anti-angiogenic mole-
cule tissue inhibitor of metalloproteinase 1 (Timp1) was upregu-
lated in FRCs, suggesting that this might regulate responses by
BECs after infection (Zanotti et al., 2016). The transcription fac-
torsBatf3 and the vitamin D receptor (Vdr) were also upregulated
uniquely in FRCs (Figure S3A). A similar number of genes were
downregulated in FRCs, including Cxcl5, Il10, Il6, Glycam1,
S100a8, and S100a9, and transcription factors, including Id3
and Klf2.
As previously described (Mueller et al., 2007), expression of
the homeostatic chemokine CCL21 in the draining bLN was
significantly reduced after infection (Figure S4B). We could not
detect regulation within our gene expression profiles, presum-
ably due to saturation of the highly abundant Ccl21a transcripts
in themicroarrays. However, significant downregulation ofCcl21
mRNA was observed by qRT-PCR in sorted FRCs 3 and 6 days
after infection (Figure S4B). Thus, activation of FRCs by infection
resulted in decreased expression of CCL21.
The bLN LECs upregulated a very large cohort of unique genes
(1,390 genes), including Il7, Ccl2, Ccl5, Ccl7, Ccl21a, Tlr13 and
downregulated molecules, including Cd226 (DNAM-1) and
Marco (Figure S3B). In comparison, bLN BECs only regulated a
relatively modest cohort of unique genes (188 genes), including
upregulation of Cxcl11, complement component 3 (C3), and
Vegfc and downregulation ofCcr7,Cxcr4, and the adrenergic re-
ceptor Adrb2 (Figure S3C). Thus, LSCs responded rapidly and
robustly to peripheral infection, suggesting complex regulation
of gene expression by LSCs in response to infection. However,
this transcriptional program was transient, as gene expression
in these cells 30 days after infection was indistinguishable to
that in uninfected cells.
Lymphocytes Induce and Sustain LSC Responses to
Infection
The prominent changes in gene expression by the LSC subsets
after HSV infection led us to examine the signals required for
expansion of these cells. Our transcriptional profiling revealed
marked upregulation of Fabp7, and we confirmed this change
by qRT-PCR in sorted FRCs (Figure 4A). Since Fabp7 has(I) Antigen non-specific B cells can sustain FRCs expansion after infection. Mice w
naive B cells from OBI-RAG/ mice. n = 6–14 mice per group. Data are pooled
Error bars represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0
two-tailed Mann-Whitney test (D), by Kruskal-Wallis test followed by Dunn’s mu
multiple-comparisons test (F). See also Figures S4 and S5.
412 Cell Reports 18, 406–418, January 10, 2017been suggested to play a role in the expansion of astrocytes
and some cancer cells (Sharifi et al., 2011), we wanted to deter-
mine whether this protein was involved in the proliferation of
FRCs after infection. Fabp7/ mice were infected with HSV
and numbers of FRCs examined in bLNs. We did not detect
any deficiency in the architecture of bLNs in these mice, and
expansion of FRCs was unaffected compared with wild-type
mice (Figure 4B). We also examined the role of various innate im-
mune sensors and signals that can contribute to immune re-
sponses to HSV, using mice deficient in interleukin 1 converting
enzyme (ICE), Trif, MyD88, toll like receptor 3 (TLR3), IL-15, and
interferon g (IFN-g). FRCs in each of these mice expanded like
control mice (Figure S4C). Similarly, mice lacking interferon reg-
ulatory factor 8 (IRF8), which have deficiencies in CD8a and
CD103+ dendritic cell populations, demonstrated normal expan-
sion of FRCs.
The type I interferon (IFN-I) signature induced by infection in
the LSC subsets led us to ask whether IFNaR signals were
required for stromal expansion. IFN-aR2/ mice infected with
HSV showed no LSC expansion on days 7 and 15 (Figure 4C).
Importantly, total cellularity in bLNs of IFN-aR2/ mice
increased minimally after HSV infection, indicating that cell
recruitment or retention in the LN was required for stromal cell
expansion. To examine this directly, we treated mice with
neutralizing antibodies to aL and a4 integrins to block LN entry,
beginning 24 hr after infection. This inhibited the accumulation of
cells in the bLN and resulted in significantly reduced expansion
of FRCs (Figure 4D), demonstrating that lymphocyte recruitment
to bLNs was critical for LSC expansion after infection.
Expansion of the bLNs or FRCs was not significantly impaired
in TCR-a/ mice, which lack mature T cell receptor ab-positive
(TCR-ab+) T cells (Figure 4E). Transfer of HSV-specific CD4+
gDT-II and CD8+ gBT-I T cells into TCR-a/mice prior to infec-
tion also did not alter FRC expansion, suggesting that antigen-
specific T cell recruitment or expansion was not required to
induce LSC growth after infection. In contrast, when we exam-
ined responses in lymphocyte-deficient RAG/ mice, we found
that expansion of the stromal cells was completely abrogated
(Figure 4F). To determine whether we could reconstitute ex-
pansion of the LN stromal compartment, RAG/ mice were
adoptively transferred with 2 3 107 total LN cells from B6
mice, 2 3 107 polyclonal T cells, or 1 3 106 gDT-II and gBT-I
T cells and then infected with HSV on the skin. Control mice
were left uninfected and analyzed 7 or 15 days after cell transfer.
Reconstitution of RAG/ mice did not induce expansion of the
bLN LSCs in the absence of infection, but it facilitated expansion
after HSV infection. Transfer of unenriched LN cells, polyclonal
T cells, or low numbers of HSV-specific T cells all triggered
robust LSC responses (Figure S5A). Although bLNs fromRAG/
mice were smaller and contained fewer LSCs than bLNs from B6
mice, the magnitude of LSC expansion was similar or greater in
RAG/ mice 7 days after infection. This suggested that theere treated as in (H), with an additional group of mice transferred with 23 107
from two or three independent experiments.
.0001 by one-way ANOVA with Dunnett’s multiple-comparisons test (A–C), by
ltiple-comparisons test (E and G–I), or by two-way ANOVA with Bonferroni’s
transferred cells were capable of triggering LSC expansion.
However, in mice receiving polyclonal or transgenic T cells,
these responses were not sustained, and by day 15 after infec-
tion, LSCs in these mice contracted (Figure 4G). In contrast,
transfer of total LN cells promoted sustained expansion of
FRCs and LECs from days 7 to 15.
Since our results suggested that T cells were not required yet
were sufficient to induce expansion of the bLN stromal popula-
tions after infection, we examined responses in mMT/ mice
that lack mature B cells but have normal numbers of T cells.
Although LSCs expanded in mMT/ mice, after day 7, numbers
of FRCs and LECs contracted, and BECs failed to expand
further, unlike B6 mice, where LSC expansion peaked at day
15 (Figures 4H and S5B). This inability to sustain LSC expansion
suggested a role for B cells in this process. To examine this, we
reconstituted mMT/ mice with polyclonal B cells from B6 mice
prior to HSV infection. Expansion of the LSCs at day 7 in these
mice was similar to mMT/ mice not given B cells. Transfer of
B cells induced sustained LN expansion (Figures 4H and S5B).
Notably, while the transfer of polyclonal T or B cells induced a
similar increase in bLN cellularity (Figure S5C), only B cells sus-
tained LSC expansion. Moreover, transfer of ovalbumin-specific
B cells from OBI-RAG/ mice (Dougan et al., 2012) demon-
strated that B cells sustained FRC expansion in a non-specific
manner (Figure 4I). These data show that either B cells or
T cells were sufficient to trigger LSC expansion, yet B cells
were required to sustain stromal cell responses.
Sustained LSC Expansion Influences Secondary
Responses
The protracted expansion of the LSC subsets after HSV infection
could reflect a programmed response that is induced by inflam-
mation, influenced by the pathogen, or both. To investigate the
kinetics of LSC responses to different viral infections, we exam-
ined proliferation in response to skin infection with HSV, vaccinia
virus (VV), or lymphocytic choriomeningitis virus (LCMV). Sur-
prisingly, the kinetics of FRC expansion was different for each
pathogen (Figure 5A). Compared to HSV infection, skin VV infec-
tion induced a peak of FRC expansion by day 7, followed by
contraction by day 15. In contrast, skin LCMV infection induced
delayed FRC expansion that peaked around day 15 and did not
contract. Despite different growth and contraction kinetics, all
three infections induced prolonged expansion of FRCs. At day
30,5- to 8-fold more FRCswere found in draining bLNs relative
to naive mice. We observed similar response kinetics for LECs
and BECs. In contrast, all three infections induced increased
LN cellularity that peaked 7 days after infection. Thus, the LSC
populations responded with different kinetics, presumably in
response to infection-specific cues, yet all induced sustained
expansion of FRCs and LECs that persisted for at least 30 days.
The marked changes in LSC gene expression induced by
HSV infection were not sustained, resulting in transcriptional
profiles at day 30 that were essentially indistinguishable from
those of uninfected mice (Figure 2A). To investigate the signifi-
cance of sustained LSC expansion for subsequent immune re-
sponses, we infected mice on the skin with HSV and 30 days
later subjected the same mice to heterologous infection with
VV or LCMV. Alternately, mice were first infected with VV and30 days later challenged with HSV. In all combinations, FRCs,
LECs, and BECs expanded with similar kinetics, peaking at
day 15, whereas LN cellularity peaked at day 7 (Figure 5B).
T cell responses and LN cellularity in naive or previously chal-
lenged mice were the same, indicating that the enlarged LN
did not influence the magnitude of subsequent responses (Fig-
ure S5D). Moreover, the number of LSCs at the peak of infection,
as well as LN cellularity, was the same during primary and sec-
ondary challenge. Furthermore, 30 days after the second infec-
tion, LSC populations contracted to levels equivalent to that at
day 30 after primary infection, indicating that successive infec-
tions did not result in progressively larger LNs. Rather, the LNs
were programmed with a new set point after an initial immune
response that persisted with subsequent challenge.
Examination of themagnitude of FRCexpansion during primary
versus secondary heterologous infections revealed that ‘‘experi-
enced’’ LNs expanded considerably less than naive LNs (Fig-
ure 5C). In particular, the extent of FRC expansion was substan-
tially lower during secondary responses, demonstrating that less
proliferationwas required to reach the samepeak level. Thus, pro-
longed LN hypertrophy sustained expansion of the FRC compart-
ment after virus infection, and this altered LN stromal niche influ-
enced the magnitude of remodeling during subsequent infection.
DISCUSSION
The marked changes in LN size and organization during immune
responses are controlled by subsets of stromal cells that con-
struct and support the tissue. We describe a comprehensive
analysis of LSC responses to infection. LN FRCs, LECs, and
BECs proliferated and expanded in number significantly after
skin HSV, VV, and LCMV infection. The kinetics of LSC expan-
sion induced by the different pathogens was distinct, yet by
1 month post-infection, the numbers of gp38+ FRCs were similar
between each infection group. Transcriptomic analysis of LSCs
revealed that coordinate regulation of large numbers of genes
defined the stromal response to infection. Both shared and
unique cohorts of genes were regulated in LSC subsets after
HSV infection. Notably, gene expression in LSCs 30 days after
infection was equivalent to that seen prior to infection, demon-
strating that the stromal cells did not generate a transcriptional
memory of the response. However, previously primed LNs sus-
tained expanded FRC networks and supported subsequent re-
sponses via reduced stromal cell expansion. These data indicate
that the requirement for LN remodeling is different in LNs previ-
ously exposed to pathogens, which has important implications
for understanding LN remodeling in humans.
LN hypertrophy or lymphadenopathy accompanies infections,
inflammation, and cancers. Recent studies have shown that im-
munization induces expansion of LSC subsets (Abe et al., 2014;
Chyou et al., 2011; Denton et al., 2014; Yang et al., 2014). Inflam-
mation induces an increase in the recruitment and retention of
lymphocytes in LN and serves to increase the likelihood that
rare naive T cells will encounter cognate antigen (Shiow et al.,
2006; Soderberg et al., 2005), yet the degree to which such
enlargement of LNs is required for the induction or maintenance
of immune responses is not clear. After skin HSV-1 infection of
mice, we observed rapid expansion of FRCs, LECs, and BECs,Cell Reports 18, 406–418, January 10, 2017 413
Figure 5. Altered Kinetics and Magnitude of LSC Responses during Secondary Infection
(A) Different kinetics of LSC expansion in response to skin infection with different viruses. Mice were infected on the scarified skin of the flank with either HSV,
vaccinia virus (VV), or LCMV Armstrong and the draining bLN analyzed on days 7 (HSV or VV) or 8 (LCMV), 15, and 30. n = 8–22 mice per group.
(B) Heterologous infection induces similar kinetics of LSC expansion irrespective of viral pathogen. Mice were infected with either HSV, VV or LCMV on the skin of
mice infected 30 days previously with either HSV, VV, or LCMV and the draining bLN analyzed on days 7 (HSV or VV) or 8 (LCMV), 15, and 30. n = 4–10 mice per
group.
(C) Reduced expansion of FRCs following a second heterologous infection on the skin. Mice were infected with HSV, VV, or LCMV, with VV followed by HSV after
30 days, or with HSV followed by VV or LCMV after 30 days. FRC expansion in bLNs was analyzed at various times after infection and plotted relative to that prior
to primary (black lines) or secondary (red lines) challenge. Data are pooled from two or three independent experiments.
Error bars represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001 by two-way ANOVA. See also Figure S5.as well as PNAd+ BECs. This LSC expansion lagged behind the
increase in immune cells within the LN, as observed previously
(Denton et al., 2014; Yang et al., 2014). Conspicuously, skin
infection with VV resulted in an earlier peak and contraction of
LSCs, whereas LCMV infection induced relatively weak re-
sponses by FRCs. This implied that pathogen-derived signals
were important for influencing the timing and magnitude of
LSC responses to infection. We identified IFN-I as one signal
mediating LSC expansion after infection, possibly via regulation
of lymphocyte recruitment and retention (Shiow et al., 2006).
However, we expect that multiple signals will contribute to this
process, dependent upon the amount and type of inflammation
induced by individual pathogens.
Recruitment of T and B cells controlled expansion of the bLN
LSCs after infection, similar to that after immunization (Yang
et al., 2014). We found that preventing the entry of immune cells
into LNs by integrin blockade after infection was sufficient to
inhibit FRC expansion, although it remains possible that integ-414 Cell Reports 18, 406–418, January 10, 2017rin-mediated interactions also contribute to this response.
RAG/ mice showed no LSC expansion, and mMT/ mice
had reduced responses, yet TCR-a/mice were largely normal.
We could restore LSC expansion in RAG/ mice by adoptive
transfer of T or B cells, yet only B cells were capable of sustaining
responses for longer than 1 week. Prior reports have shown that
expansion of LN lymphatics and vasculature can be controlled
by B cells (Angeli et al., 2006; Kumar et al., 2010), a process
that required lymphotoxin LT-ab expression by B cells. We do
not yet know whether B cells also sustain FRC responses after
infection in an LT-ab-dependent manner. Remodeling of LN
medullary regions during inflammationwas also shown to require
B cells and involve LT-ab signals (Abe et al., 2014). We observed
similar changes after HSV infection and a sustained increase in
gp38+ FRCs in the medulla. Although we could not distinguish
medullary FRCs by flow cytometry, it will be important to deter-
mine how this population contributes to responses in compari-
son to T cell zone FRCs.
Expression of gp38 was increased on FRCs and LECs, corre-
lating with increased numbers of DCs in the bLNs. Recent re-
ports have shown that DCs expressing Clec2 can overcome
gp38-induced contractility in FRCs, permitting stretching of the
stromal network (Acton et al., 2014; Astarita et al., 2015). This
may facilitate very early expansion of LNs by relaxing the stromal
network. However, once the FRCs proliferate, upregulation of
gp38 might be required to enforce FRC contractility as the num-
ber of DCs increases. Since gp38 also influences DC migration
(Acton et al., 2012) and maintains the integrity of HEVs (Herzog
et al., 2013), upregulation of gp38 during inflammation and LN
expansion could ensure such processes are preserved. DCs
were also shown to promote FRC survival during immune re-
sponses via gp38 upregulation (Kumar et al., 2015). All LSC sub-
sets also increased expression of versican. Overexpression of
versican in human dermal fibroblasts can lead to increased
SMA expression and enhanced cell contractility (Hattori et al.,
2011), suggesting that this might also help to sustain the integrity
of the LSC networks during LN expansion.
We describe the transcriptional signatures of LSC subsets dur-
ing infection. The number of genes regulated by FRCs, LECs, and
BECs after infection was surprising. In particular, FRCs and LECs
each up- or downregulated more than 1,000 genes. We identified
numerous immune-related genes in each subset that were
increased after infection. All three LSC subsets upregulated the
chemokine Cxcl9, which can play important roles in T cell re-
sponses. The LSC subsets also increased expression of various
MHC II genes and showed increased cell surface expression,
particularly on FRCs. MHC II complexes acquired by LSCs from
DCs can contribute to T cell peripheral tolerance (Dubrot et al.,
2014), while LSC MHC II expression may also contribute to regu-
latory T cell maintenance (Baptista et al., 2014). Whether
increasedMHC II expression during immune responses can influ-
ence T cell responses will be important to assess.
The LN LSCs also regulated multiple cytokine and chemokine
genes after infection. Our data suggest that FRCs are a promi-
nent source of IL-33 in LNs after infection. IL-33 has been shown
to be important for CTL responses after LCMV and murine
g-herpesvirus 68 infection (Bonilla et al., 2012). Additionally,
many genes involved in cellular adhesion, cytoskeleton, extra-
cellular matrix, metabolism, and cell growth were transcription-
ally regulated by LSCs, as well as numerous transcription fac-
tors, including those involved in inflammation and cytokine
signaling. These transcriptional signatures will be important for
dissection of the roles of LSCs in LN expansion and immune
responses.
We were surprised to find that gene expression in all LSC
subsets returned to homeostatic levels within 30 days of infec-
tion, without any ‘‘memory’’ signature. This demonstrates that
infection did not induce differentiation of the LSCs, at least at
the population level. Further, this shows that LSCs can quickly
establish quiescence after infection, despite maintaining
increased populations, particularly in the case of FRCs. The
LSC response to infection also contrasts with transcriptional
changes induced in FRCs in tumor draining LNs, where fewer
and considerably more modest gene expression changes were
observed (Riedel et al., 2016). However, both infection and
tumors regulated genes, including Thy1, Aqp1, Cyp2f2, andCcl21, in FRCs, suggesting that these are programmed path-
ways important to support immune responses. In particular,
CCL21 downregulation may support immune responses.
The amplified populations of LN FRCs were sustained for at
least 3 months after infection, suggesting that the initial remod-
eling of naive LNs by infection lastingly altered the cellular archi-
tecture. Furthermore, we found that after a second unrelated
infection, LSC expansion did not exceed the maximal level
observed during the primary infection. Thus, a hallmark of LSC
responses in experienced LNs was reduced expansion, poten-
tially placing less physical and metabolic stress on the tissue
to achieve the same outcome. Moreover, the FRCs and LECs
contracted to the new baseline set by the primary infection,
and the total cellularity of these LN remained largely unchanged,
as previously described following multiple heterologous prime-
boost vaccinations (Vezys et al., 2009).
Thus, our experiments reveal that an immune response can
induce prolonged changes in LNs that may support subsequent
immune challenges through boosted stromal cell populations.
Recent experiments have shown the influence of broadmicrobial
exposure on the cells of the immune system (Beura et al., 2016),
suggesting that this may also translate to remodeling of the
lymphoid tissues. As such, the LSC responses to heterologous
infections we describe here may be more akin to LN remodeling
in humans, since we are regularly exposed to microbes. It will be
important to ascertain how different human pathogens alter stro-




C57BL/6, gBT-I (Mueller et al., 2002), gDT-II, FABP7/ (Tokuda et al., 2010),
OBI.RAG/ (Dougan et al., 2012), IFN-aR2/, RAG1/Je/, TCR-a/,
mMT/, ICE/, TLR3/, TRIF/, MyD88/, IRF8/, IL-15/, and IFN-
g/ mice were bred in the Department of Microbiology and Immunology.
gBT-I and gDT-II mice expressing T cell receptors recognizing the HSV-1
glycoprotein B-derived epitope gB498-505 and glycoprotein D-derived epitope
gD315–327, respectively. Animal experiments were approved by The University
of Melbourne Animal Ethics Committee.
Virus Infections
Mice were infected on the skin of the flank with either 106 plaque-forming units
(PFUs) of HSV-1 (KOS) or vaccinia virus (CR-19) or 104 PFUs of LCMV (Arm-
strong) by scarification. Mice were anaesthetized by intraperitoneal (i.p.) injec-
tion of a 1:1 mixture of ketamine and Xylazil (10 mL/g body weight). Hair was
removed from the left flank of each mouse with clippers and depilation cream
(Veet, Reckitt Benckiser) and a small area of skin (2–4 mm2) corresponding
with the top of the spleen was lightly abraded using a Dremel power tool
and bullet-shaped sanding tip before inoculation of virus in a 10 mL volume.
The infection site was then covered with a piece of OpSite Flexigrid and
secured withMicropore tape and Transpore tape (3M) for 48 hr following infec-
tion. For secondary infections, mice were infected with 106 PFUs of HSV-1 or
vaccinia virus or 104 PFUs of LCMV 30 days after primary infection.
Stromal Cell Isolation and Flow Cytometry
Brachial and inguinal lymph nodes were harvested, teased apart with forceps,
and incubated at 37C in RPMI containing 1.5 mg/mL Collagenase D (Roche),
0.1 mg/ml DNase (Sigma), and 5% fetal calf serum (FCS) for 20 min. Tissues
were incubated for a further 15min at 37Cwith the addition of 0.8 mg/mL Dis-
pase (Roche) and re-suspended every 5 min. Remaining tissue pieces were
further digested in fresh digest medium for 10 min. Single-cell suspensionsCell Reports 18, 406–418, January 10, 2017 415
were then stained with antibodies for flow cytometry. The following antibodies
fromBDBiosciences were used: fluorescein isothiocyanate (FITC)-conjugated
CD8 (53-6.7, 1/400), allophycocyanin (APC)-conjugated CD45.1 (A20, 1/200)
and CD45.2 (104, 1/100), phycoerythrin (PE)-conjugated CD4 (RM4-4,
1/300), Alexa-Fluor-700-conjugated major histocompatibility complex class
II (IA/IE) (M5/114.15.2, 1/200), PE-conjugated gp38 (8.1.1, 1/200), Alexa-
488-conjugated HEVs (MECA 79, 1/200), PE Cy7-conjugated CD31 (MEC
13.3, 1/200), PE Cy7-conjugated CD11c (N418, 1/400), APC-conjugated
CD19 (1D3, 1/100), APC-conjugated CD21/35 (7G6, 1/100), and APC-conju-
gated BrdU (1/50); purified CD16/32 (2.4G2, 1/200) was used to block nonspe-
cific Fc receptor binding. Propidium iodide was used to exclude dead cells.
FACSCanto II (BD) and FlowJo software (TreeStar) packages were used for
analysis.
For cell sorting, cell suspensions were first depleted of CD45+ cells utilizing
CD45+ magnetic-activated cell sorting (MACS) beads according to the manu-
facturer’s instructions (Miltenyi Biotec). Cells were stained for CD45, gp38,
CD31, and CD21/35 to exclude FDCs. On average, less than 1%of gp38+ cells
were CD21/35+ in naivemice. An FACSAria III (BD) was used for sorting using a
100-mm nozzle at 20 psi.
Gene Expression Microarrays
Stromal cell subsets from bLN were sorted into RPMI containing 10%
FCS, immediately collected by centrifugation, snap frozen in liquid N2, and
stored at 80C after cell sorting. RNA was isolated utilizing the RNAeasy
kit (QIAGEN) according to manufacturer’s instructions. RNA quality and quan-
tity was assessed with a Bioanalyzer 2100 (Agilent) and an RNA 6000 Pico kit
(Agilent). RNAwas subsequently amplified and converted into cDNA by a linear
amplification method with the WT-Ovation Pico System (Nugen), the cDNA
was labeled with the Encore Biotin module (Nugen) and hybridized to Gene-
Chip MouseGene 1.0 ST chips (Affymetrix) at the Molecular Genomics Core
Facility of the Peter MacCallum Cancer Centre in Australia.
Bioinformatics analysis used Bioconductor software (Huber et al., 2015). Mi-
croarray intensities were background corrected, normalized, and summarized
by probe set using robust multi-array analysis (RMA) (Irizarry et al., 2003).
Probe-set annotation was obtained from the Affymetrix file ‘‘MoGene-1_
0-st-v1.na31.mm9.transcript.csv’’ and from the org.Mm.eg.db annotation
package. Control probe sets were removed. Probe sets were retained for
downstream analysis if they were in the top 75% of intensities in three or
more samples. Differential expression analysis was undertaken using linear
modeling in the limma software package (Ritchie et al., 2015). Correlation be-
tween samples from the same cell sort was modeled using limma’s duplicate
correlation function (Smyth et al., 2005). Differential expression was assessed
using TREAT empirical Bayes t tests relative to a fold change threshold of 1.1
(McCarthy and Smyth, 2009) and the FDR was controlled at 5%. The TREAT
method requires genes to have expression changes significantly above the
specified threshold. For this study, the statistically significant fold changes
were almost all (97%) greater than 1.5-fold andmost greater than 2-fold. Multi-
dimensional scaling plots were drawn using limma’s plotMDS function using
leading fold change distances.
qRT-PCR
For qRT-PCR analysis of the expression of Fabp7 and Ccl21, RNA was
extracted with an RNeasy Micro Kit (QIAGEN), and cDNA was synthesized
with SuperScript III Reverse Transcriptase (Invitrogen) and oligo(dT) primers
(Promega). Fast SYBR green Master mix (Life Technologies) was used
for qRT-PCR. Primer sequences were 50-GGGTAAGACCCGAGTTCCTC-30
and 50-GAGCTTGTCTCCATCCAACC-30 for Fabp7 and 50-ATCCCGGCAA
TCCTGTTCTC-30 and 50-GGTTCTGCACCCAGCCTTC-30 for Ccl21. Expres-
sion for each sample was calculated by the 2DCt method.
Adoptive Transfer of Lymphocytes
Naive gBT-I.Ly5.1 and gDT-II.Ly5.1 cells were isolated from LN and spleen,
and gDT-II cells were further enriched by positive and negative selection using
magnetic beads, as described previously (Hor et al., 2015). T or B cells were
enriched from pooled LN and spleens of naive B6 mice using MACS beads.
Naive mice received gBT-I.Ly5.1 and gDT-II.Ly5.1 cells, enriched T cells
or B cells, or suspensions of LN cells intravenously via the tail vein (see figure416 Cell Reports 18, 406–418, January 10, 2017legends for the number of cells transferred). In-vitro-activated gBT-I effector
cells were activated by peptide-pulsed splenocytes as previously described
(Mackay et al., 2012), and 5 3 104 cells were injected intravenously 3 days
post-HSV-1 infection.
Integrin Blockade and BrdU Labeling
To block entry of lymphocytes to the LN, mice received 100 mg of the function-
blocking antibodies to the integrins a4 (PS/2) and aL (M17/4) on days 1, 3, and
5 post-infection via i.p. injection. To assess proliferation of stromal cell popu-
lations, mice received 0.25 mg/mL BrdU (BD Biosciences) via i.p. injection
followed by continuous labeling with BrdU in drinking water (0.8 mg/mL) for
the periods days 0–7, days 7–11, and 11–15 post-infection.
ELISA
Tissues were removed from mice and placed in PBS supplemented with 1%
BSA and 10 mL/mL protease inhibitor cocktail P8340 (Sigma-Aldrich). Tissue
was homogenized and supernatant used for ELISA. Detection of mouse
CCL21 was performed using a DuoSet ELISA development kit (R&D Systems)
as per the manufacturer’s instructions.
Immunofluorescence and Confocal Microscopy
Lymph nodes were harvested and fixed in periodate-lysine-paraformaldehyde
(PLP) fixative for 4–8 hr, incubated in 20%sucrose overnight at 4C. Tissue sec-
tions were cut at 6 mm thickness with a cryostat (Leica CM3050S) and air-dried
before being fixed in acetone for 5 min, dried, and then blocked for 20min (Pro-
tein Block X0909, DAKO) at room temperature (RT). Sections were then stained
with primary antibodies for 1.5 hr, washed in PBS for 10 min, and stained with
secondary antibodies for 30 min. Images were acquired with an LSM710
confocal microscope (Carl Zeiss) and processed with Imaris (Bitplane) and
Photoshop (Adobe). The following antibodies were used: Alexa-Fluor-647-con-
jugatedB220 (1/100), Alexa-Fluor-405-conjugatedCD3 (1/100), Alexa-488-con-
jugated CD31 (1/200), Alexa-Fluor-647-conjugated Ki67 (1/200), Alexa-488-
conjugated HEV (1/200), polyclonal anti-LYVE-1 (1/400), and anti-podoplanin
(8.1.1, supernatant). Appropriate secondary antibodies from Life Technologies
were Alexa Fluor goat anti-hamster 568 (1/1,000), donkey anti-rabbit 647
(1/1,000), and donkey anti-rat 488 (1/1,000).
Statistical Analysis
Graphs were plotted using Prism 5 (GraphPad), and comparison of datasets
was performed by one- or two-way analysis of variance, or Mann-Whitney t
tests, as indicated. All graphs depict means ± SEM. The appropriate statistical
methods were chosen according to experimental setup and data distribution.
Sample sizes were chosen on the basis of previous experiences with the rele-
vant experimental models.
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